FWIW:
Citi believes Karoon has the funds to continue with the Browse appraisal but will need to farm down either Brazil or Browse prior to commencing the Brazil appraisal in the second half. The broker considers the current discount in the share price, which stems from market concerns about farming down, is not warranted, given the value of the underlying assets.
The rating is upgraded to Buy/High Risk from Neutral/High Risk. The target is reduced to $5.88 from $6.27.
Upgrade to Buy from Neutral
- Forums
- ASX - By Stock
- KAR
- upgrade
upgrade, page-3
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.34 |
Change
-0.035(2.55%) |
Mkt cap ! $1.030B |
Open | High | Low | Value | Volume |
$1.35 | $1.36 | $1.32 | $6.009M | 4.500M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3803 | $1.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.34 | 75802 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 46102 | 1.330 |
21 | 105072 | 1.325 |
27 | 146528 | 1.320 |
18 | 233229 | 1.315 |
23 | 108813 | 1.310 |
Price($) | Vol. | No. |
---|---|---|
1.335 | 45660 | 20 |
1.340 | 82705 | 14 |
1.345 | 73794 | 12 |
1.350 | 139324 | 9 |
1.355 | 118946 | 4 |
Last trade - 15.10pm 13/11/2024 (20 minute delay) ? |
Featured News
KAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online